ACE inhibitor ( DrugBank: - )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
66	IgA nephropathy	3

66. IgA nephropathy

---

Clinical trials : 255 /  Drugs : 255 - (DrugBank : 79) / Drug target genes : 35 - Drug target pathways : 137

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02981212 (ClinicalTrials.gov)	June 2016	24/11/2016	Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA Nephropathy	Multi-center, Randomized, Open Label, Comparative, Phase IV Study to Evaluate the Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid for 48 Weeks in Advanced IgA Nephropathy	IgA Nephropathy	Drug: Mycophenolate Mofetil;Drug: ACE inhibitor;Drug: Corticosteroid;Drug: ARB	Yonsei University	Chong Kun Dang Pharmaceutical Corp.;Kyung Hee University Hospital at Gangdong;Kyungpook National University;Pusan National University Yangsan Hospital;Inje University;Seoul St. Mary's Hospital;Chonbuk National University Hospital	Recruiting	19 Years	65 Years	Both	100	Phase 4	Korea, Republic of
2	NCT03015974 (ClinicalTrials.gov)	January 2016	3/1/2017	Registry of IgA Nephropathy in Chinese Children	Registry of IgA Nephropathy in Chinese Children	IgA Nephropathy;Proteinuria in Nephrotic Range;Immunosuppressive Treatment	Drug: Corticosteroid;Drug: Cyclophosphamide;Drug: Mycophenolate mofetil;Drug: Dipyridamole;Drug: ACE Inhibitor or Angiotensin receptor antagonist	Peking University First Hospital	Nanjing PLA General Hospital;Beijing Children's Hospital;Central South University;The Children's Hospital of Zhejiang University School of Medicine;First Affiliated Hospital, Sun Yat-Sen University;Tongji Hospital;Hunan Children's Hospital;Shanghai Children's Hospital;Nanjing Children's Hospital;Children's Hospital of Chongqing Medical University;Shandong Provincial Hospital;Fuzhou General Hospital;Second Affiliated Hospital of Wenzhou Medical University;Children's Hospital of Hebei Province;Guangzhou Women and Children's Medical Center;Jiangxi Province Children's Hospital;Guangzhou First People's Hospital;Xian Children's Hospital;Capital Institute of Pediatrics, China;First Hospital of Jilin University;Wuhan Women and Children's Medical Center;Tianjin Children's Hospital;Chengdu Women's and Children's Central Hospital;The First People's Hospital of Yunnan	Recruiting	1 Month	18 Years	All	1200		China
3	NCT00396721 (ClinicalTrials.gov)	January 2006	3/11/2006	Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy	Pilot Trial of Treatment of Poor-Prognosis IgA Nephropathy With Low Exposure to Sirolimus.	Glomerulonephritis, IGA;Nephropathy, IGA;IGA Nephropathy	Drug: ACE inhibitor + statin;Drug: Sirolimus (study drug)+ACE inhibitor + statin	Josep m Cruzado	Wyeth is now a wholly owned subsidiary of Pfizer	Completed	18 Years	70 Years	Both	23	Phase 2	Spain